Tools
Heinz Body
Definition/Introduction
Heinz bodies, initially known as Heinz-Ehrlich bodies, were first described by Dr Robert Heinz in 1890. Heinz bodies are indicative of oxidative injury to the erythrocyte. Heinz bodies are inclusions of irreversibly denatured hemoglobin attached to the erythrocyte cell membrane. Studies have shown that antioxidants may reduce Heinz body formation.[1]
Oxidative damage may be incurred by external substances or due to hereditary enzyme or hemoglobin defects.[2][3] More significant oxidative damage is believed to increase Heinz body formation and adhesion to the erythrocyte inner cellular membrane. Heinz bodies reduce the elasticity and deformability of the erythrocyte, increasing the likelihood of splenic destruction. Splenic macrophages remove the damaged portions of the erythrocyte membrane, resulting in the formation of bite cells. Bite cells and the resulting spherocytes are at increased risk of extravascular hemolysis, which may lead to oxidant-induced hemolytic anemia.
Heinz bodies do not generate reactive oxygen species (ROS); instead, ROS drive their formation. Severe oxidative injury may also trigger intravascular hemolysis, resulting in hemoglobinemia and hemoglobinuria. Additionally, oxidative stress can induce methemoglobinemia by oxidizing ferrous iron to ferric iron, thereby impairing hemoglobin's oxygen-carrying capacity.
Heinz bodies may be small or relatively large and prominent. In some instances, a single erythrocyte may have several small Heinz bodies. Heinz bodies are not visible with routine Wright or Diff-Quik stains. Laboratory stains can create confusion with other inclusion anomalies, including the reticulofilamentous material of reticulocytes, Pappenheimer bodies (basophilic iron deposits), Howell-Jolly bodies (nuclear fragments), and Hemoglobin H inclusions (beta-chain tetrameric precipitates).[4] These otherwise difficult-to-visualize inclusions are readily observable with supravital stains such as methylene blue.
On microscopy, Heinz bodies appear as small, dark, round inclusions and are typically located near the inner membrane of the red blood cell.[5]
Issues of Concern
Register For Free And Read The Full Article
Search engine and full access to all medical articles- 10 free questions in your specialty
- Free CME/CE Activities
- Free daily question in your email
- Save favorite articles to your dashboard
- Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Issues of Concern
Heinz bodies increase the risk of hemolytic anemia, which can present with symptoms including jaundice, dyspnea, tachycardia, hematuria, fatigue, and even hypotension. These symptoms must be recognized as early as possible to limit the severity of the anemia and its related complications.[6][7][8]
Clinical Significance
Heinz body formation, precipitation, and resulting cellular membrane damage are causes of hemolytic anemia. In addition, Heinz body hemolytic anemia may be associated with exposure to toxins such as propylene glycol, Brassica species, and henna.[9]
Cases of Heinz body hemolytic anemia may also result from genetic defects in the molecular milieu that protects erythrocytes from oxidative damage. Heinz bodies may be present in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency and those with methemoglobinemia.[10] Heinz bodies may also indicate unstable hemoglobins, such as Hb Köln or Hb Wien; they are evident in beta-thalassemia.[11][12] Heinz body production is among the dysmorphisms caused by oxidative stress in COVID-19 infection.[13][14]
Erythrocyte oxidative damage with resulting Heinz body formation can occur in various clinical conditions, especially in patients experiencing diabetic ketoacidosis.[15] Drugs acting as oxidants also cause Heinz body formation; examples include dapsone, primaquine, sulfonamides, and nitrofurantoin. Mineral deficiencies, such as selenium deficiency, also increase susceptibility to oxidative damage and Heinz body formation.
The presence of Heinz bodies can ultimately result in hemolytic anemia, and the ability to recognize signs and symptoms of hemolytic anemia is the best way to maximize patient-centered care. Although hemolytic anemia is often diagnosed through laboratory assessment, it is crucial to recognize classic signs of anemia: fatigue, dyspnea, pallor, jaundice, and organomegaly. Being well-versed in identifying these clinical presentations maximizes patient safety and quality of care.[16]
No specific treatment exists for oxidation-induced erythrocyte damage beyond the removal of the offending agent and supportive care. If chronic hemolysis is present, bilirubin gallstones and iron overload may occur; splenectomy is the treatment of choice for some causes of hemolytic anemia.[11] Patients with hemoglobinopathies may benefit from genetic counseling.
Nursing, Allied Health, and Interprofessional Team Interventions
Management of Heinz body–associated hemolysis requires prompt, coordinated actions from the healthcare team to address the underlying cause and prevent further red cell damage. Clinicians and advanced practitioners focus on identifying and removing precipitating factors such as oxidative drugs or toxins, evaluating the severity of anemia, and initiating appropriate treatment, including transfusion when clinically indicated.[17] Pharmacists contribute by reviewing and optimizing the medication regimen, discontinuing or substituting offending agents, and ensuring safe pharmacotherapy.
Nurses are responsible for implementing prescribed interventions, safely administering medications and transfusions, maintaining patient comfort, and providing patient education on avoiding triggering substances. Laboratory personnel support the team by performing and reporting essential investigations, including peripheral blood smear analysis, to confirm the presence of Heinz bodies and assist in diagnostic clarification. Effective communication and coordination among all team members ensure timely decision-making and patient-centered care, improving outcomes and reducing the risk of complications.
Nursing, Allied Health, and Interprofessional Team Monitoring
Ongoing monitoring is essential to assess the patient’s response to treatment and detect any progression of hemolysis or development of complications. Nurses play a central role in continuous bedside observation, including monitoring vital signs, oxygen saturation, urine color, and overall clinical status, while also noting any signs of worsening anemia or hemodynamic instability. Clinicians and advanced practitioners reassess the patient regularly, correlating clinical findings with laboratory trends, including hemoglobin levels, reticulocyte counts, and markers of hemolysis.
Laboratory professionals ensure timely reporting of follow-up investigations, including repeat peripheral blood smears when needed. Pharmacists continue to monitor medication safety and adherence to avoid re-exposure to causative agents. Clear and consistent communication among all team members enables early identification of clinical changes, supports timely management adjustments, and ensures safe, coordinated, and effective patient care.[18][19]
References
Palasuwan A, Soogarun S, Lertlum T, Pradniwat P, Wiwanitkit V. Inhibition of Heinz body induction in an in vitro model and total antioxidant activity of medicinal Thai plants. Asian Pacific journal of cancer prevention : APJCP. 2005 Oct-Dec:6(4):458-63 [PubMed PMID: 16435991]
Reinhart WH, Sung LP, Chien S. Quantitative relationship between Heinz body formation and red blood cell deformability. Blood. 1986 Dec:68(6):1376-83 [PubMed PMID: 3779102]
Jacob H, Winterhalter K. Unstable hemoglobins: the role of heme loss in Heinz body formation. Proceedings of the National Academy of Sciences of the United States of America. 1970 Mar:65(3):697-701 [PubMed PMID: 5267148]
Gaur M, Sehgal T. Reticulocyte count: a simple test but tricky interpretation! The Pan African medical journal. 2021:40():3. doi: 10.11604/pamj.2021.40.3.31316. Epub 2021 Sep 2 [PubMed PMID: 34650653]
Christopher MM, White JG, Eaton JW. Erythrocyte pathology and mechanisms of Heinz body-mediated hemolysis in cats. Veterinary pathology. 1990 Sep:27(5):299-310 [PubMed PMID: 2238384]
Level 3 (low-level) evidencePhillips J, Henderson AC. Hemolytic Anemia: Evaluation and Differential Diagnosis. American family physician. 2018 Sep 15:98(6):354-361 [PubMed PMID: 30215915]
Dhaliwal G, Cornett PA, Tierney LM Jr. Hemolytic anemia. American family physician. 2004 Jun 1:69(11):2599-606 [PubMed PMID: 15202694]
Guillaud C, Loustau V, Michel M. Hemolytic anemia in adults: main causes and diagnostic procedures. Expert review of hematology. 2012 Apr:5(2):229-41. doi: 10.1586/ehm.12.3. Epub [PubMed PMID: 22475291]
Khefacha L, Berrayana N, Rouag H, Benhamida H, Sassi M. Henna-induced Heinz bodies in glucose-6-phosphate dehydrogenase-deficient newborn. International journal of laboratory hematology. 2022 Feb:44(1):59-60. doi: 10.1111/ijlh.13713. Epub 2021 Sep 29 [PubMed PMID: 34585532]
Ballin A, Brown EJ, Zipursky A. Idiopathic Heinz body hemolytic anemia in newborn infants. The American journal of pediatric hematology/oncology. 1989 Spring:11(1):3-7 [PubMed PMID: 2712239]
Level 3 (low-level) evidenceHilbert S, Voill-Glaninger A, Höller B, Minkov M. Hemolytic anemia due to the unstable hemoglobin Wien: manifestations and long-term course in the largest pedigree identified to date. Haematologica. 2020 May:105(5):e253-e255. doi: 10.3324/haematol.2019.236562. Epub 2020 Feb 6 [PubMed PMID: 32029504]
Sagar CS, Kumar R, Sharma DC, Kishor P. DNA damage: beta zero versus beta plus thalassemia. Annals of human biology. 2015:42(6):585-8. doi: 10.3109/03014460.2014.990921. Epub 2014 Dec 26 [PubMed PMID: 25541274]
Perrin J, Gérard D. Heinz bodies in COVID-19. International journal of laboratory hematology. 2022 Dec:44(6):1013-1014. doi: 10.1111/ijlh.13926. Epub 2022 Jun 25 [PubMed PMID: 35751427]
Zamd M, Mtioui N, Maoujoud O, Ramdani B. An unorthodox pathophysiology of severe cases of COVID-19 the weak heme hypothesis. American journal of blood research. 2020:10(6):305-310 [PubMed PMID: 33489438]
Level 3 (low-level) evidenceChristopher MM, Broussard JD, Peterson ME. Heinz body formation associated with ketoacidosis in diabetic cats. Journal of veterinary internal medicine. 1995 Jan-Feb:9(1):24-31 [PubMed PMID: 7891359]
Level 3 (low-level) evidenceRuiz EF, Cervantes MA. Diagnostic approach to hemolytic anemias in the adult. Revista brasileira de hematologia e hemoterapia. 2015 Nov-Dec:37(6):423-5. doi: 10.1016/j.bjhh.2015.08.008. Epub 2015 Oct 9 [PubMed PMID: 26670408]
Kim Y, Park J, Kim M. Diagnostic approaches for inherited hemolytic anemia in the genetic era. Blood research. 2017 Jun:52(2):84-94. doi: 10.5045/br.2017.52.2.84. Epub 2017 Jun 22 [PubMed PMID: 28698843]
Meneses-La-Riva ME, Fernández-Bedoya VH, Suyo-Vega JA, Ocupa-Cabrera HG, Grijalva-Salazar RV, Ocupa-Meneses GDD. Enhancing Healthcare Efficiency: The Relationship Between Effective Communication and Teamwork Among Nurses in Peru. Nursing reports (Pavia, Italy). 2025 Feb 7:15(2):. doi: 10.3390/nursrep15020059. Epub 2025 Feb 7 [PubMed PMID: 39997795]
Rosen MA, DiazGranados D, Dietz AS, Benishek LE, Thompson D, Pronovost PJ, Weaver SJ. Teamwork in healthcare: Key discoveries enabling safer, high-quality care. The American psychologist. 2018 May-Jun:73(4):433-450. doi: 10.1037/amp0000298. Epub [PubMed PMID: 29792459]
Level 2 (mid-level) evidence